Abstract

ObjectiveApparent diffusion coefficient (ADC) values calculated through magnetic resonance imaging have been proposed as a useful tool to distinguish benign from malignant liver lesions. Most studies however included simple cysts in their analysis. Liver cysts are easy to diagnose, have very high ADC values and their inclusion facilitates differentiation in the ADC values between benign and malignant liver lesions groups. We prospectively evaluated the ability of ADC values to differentiate metastatic liver lesions from all benign or only solid benign liver lesions.Material and MethodsSixty-seven adult cancer patients with 188 liver lesions were evaluated. Lesions were categorized as metastatic or benign throughout imaging and clinical evaluation. One hundred and five (105) metastatic lesions and 83 benign lesions including hemangiomas (37), cysts (42), adenomas (2) and focal nodular hyperplasias (2) were evaluated. ADC values were calculated for each lesion utilizing two b values (0 and 600 sec/mm2).ResultsThe average ADC value for cysts was 2.4×10−3 mm2/sec (CI: 2.1–2.6), for solid benign lesions was 1.4×10−3 mm2/sec (CI: 1.1–1.7) and for metastases was 1.0×10−3 mm2/sec (CI: 0.8–1.3). There was a difference between the ADC values of metastases and benign solid lesions (p<0.0001). With the ADC value of 1.5×10−3 mm2/sec as a cut off it is possible to distinguish metastatic from benign liver lesions, including cysts, with an accuracy of 78%. But to distinguish metastatic from benign solid liver lesions the best ADC cut off value was 1.2×10−3 mm2/sec and the accuracy drops to 71%.ConclusionsADC values proved to be helpful in the distinction between metastasis and benign solid hepatic lesions. But the exclusion of cysts in the analysis point out to a lower cut off value and lower accuracy than previously reported.

Highlights

  • The liver is a common site of hematogenous metastases

  • There was a difference between the Apparent diffusion coefficient (ADC) values of metastases and benign solid lesions (p,0.0001)

  • To distinguish metastatic from benign solid liver lesions the best ADC cut off value was 1.261023 mm2/sec and the accuracy drops to 71%

Read more

Summary

Introduction

The liver is a common site of hematogenous metastases. Gastrointestinal and neuroendocrine tumors as well as melanoma are the most common primary sites responsible for metastatic liver involvement [1,2]. Ultrasound (US), computed tomography (CT) and magnetic resonance imaging (MRI) are the commonly used to detect and evaluate focal liver lesions [3]. MR of liver depends on the signal characteristics (T1 and T2 weighted signal intensities) and post-Gd imaging. The combination of these imaging techniques provides anatomic and functional imaging information to best detect and diagnose liver pathology. Recent applications of new functional methods, especially diffusion-weighted imaging (DWI), have expanded the use of MRI in the evaluation of lesions suspected for malignancy [4,5]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call